Huiyu Pharmaceutical has announced that three of its products have been selected for the twelfth batch of national centralized drug procurement. The company participated in the bidding process organized by the National Joint Procurement Office, and the preliminary results公示ed on July 31, 2026, indicate that its injectable epirubicin hydrochloride, injectable teicoplanin, and calcium folinate injection were successful bids. Separately, Xiaomi has officially launched its Xiaomi Longjia battery system, which is a systematic solution for power batteries led by Xiaomi Auto. This system boasts safety standards that far exceed national standards, with a comprehensive quality control system including a "shadow factory" management approach, full-process penetration quality inspection utilizing AI, and unique electronic identification for each battery cell to ensure traceability. AI
IMPACT Xiaomi's new battery system incorporates AI for quality control, potentially improving manufacturing efficiency and product reliability in the electric vehicle sector.
RANK_REASON The cluster contains two distinct news items: one about pharmaceutical procurement and another about a new battery system, neither of which meets the criteria for frontier_release, significant, or research. They are best categorized as product/policy updates.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
